ADARx Pharmaceuticals, Inc. (ADRX) Form 10-K Annual Reports
ADARx Pharmaceuticals, Inc. (ADRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ADRX
CIK: 1802369
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor Since2025
Lead Engagement PartnerKelly Hayes
Audit LocationSan Diego, California
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D | 2026-10-02 | — | 0000947871-26-000917 | View SEC Doc Filr Page | |
| SCHEDULE 13G | 2026-10-01 | — | 0001193125-26-410626 | View SEC Doc Filr Page | |
| 4 | 2026-09-30 | 2026-09-28 | 0000947871-26-000912 | View SEC Doc Filr Page | |
| 4 | 2026-09-30 | 2026-09-28 | 0000947871-26-000911 | View SEC Doc Filr Page | |
| 4 | 2026-09-30 | 2026-09-28 | 0000947871-26-000910 | View SEC Doc Filr Page | |
| 4 | 2026-09-29 | 2026-09-28 | 0001193125-26-408064 | View SEC Doc Filr Page | |
| 4 | 2026-09-29 | 2026-09-28 | 0001193125-26-408061 | View SEC Doc Filr Page | |
| 4 | 2026-09-29 | 2026-09-28 | 0001231919-26-001406 | View SEC Doc Filr Page | |
| S-8 | 2026-09-28 | — | 0001193125-26-405447 | View SEC Doc Filr Page | |
| 4 | 2026-09-28 | 2026-09-24 | 0002153958-26-000004 | View SEC Doc Filr Page | |
| 4 | 2026-09-28 | 2026-09-24 | 0002154450-26-000004 | View SEC Doc Filr Page | |
| 4 | 2026-09-28 | 2026-09-24 | 0002151480-26-000004 | View SEC Doc Filr Page | |
| 4 | 2026-09-28 | 2026-09-24 | 0001729510-26-000006 | View SEC Doc Filr Page | |
| 4 | 2026-09-28 | 2026-09-24 | 0002153534-26-000004 | View SEC Doc Filr Page | |
| 8-K | 2026-09-28 | 2026-09-28 | 0001193125-26-405297 | View SEC Doc Filr Page | |
| 424B4 | 2026-09-28 | — | 0001193125-26-403094 | View SEC Doc Filr Page | |
| EFFECT | 2026-09-24 | — | 9999999995-26-003052 | View SEC Doc Filr Page | |
| 3 | 2026-09-24 | 2026-09-24 | 0001193125-26-401301 | View SEC Doc Filr Page | |
| 3 | 2026-09-24 | 2026-09-24 | 0001193125-26-401300 | View SEC Doc Filr Page | |
| 3 | 2026-09-24 | 2026-09-24 | 0000947871-26-000882 | View SEC Doc Filr Page | |
| 3 | 2026-09-24 | 2026-09-24 | 0001231919-26-001226 | View SEC Doc Filr Page | |
| 3 | 2026-09-24 | 2026-09-24 | 0001967360-26-000011 | View SEC Doc Filr Page | |
| 3 | 2026-09-24 | 2026-09-24 | 0001323304-26-000004 | View SEC Doc Filr Page | |
| 3 | 2026-09-24 | 2026-09-24 | 0002153534-26-000002 | View SEC Doc Filr Page | |
| 3 | 2026-09-24 | 2026-09-24 | 0001706399-26-000002 | View SEC Doc Filr Page |